Avidity Biosciences (NASDAQ:RNA) Trading Down 4.3%

Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) traded down 4.3% on Tuesday . The stock traded as low as $26.07 and last traded at $26.27. 447,285 shares were traded during mid-day trading, a decline of 60% from the average session volume of 1,124,135 shares. The stock had previously closed at $27.45. Analyst […]

Related Keywords

United States ,China ,America ,Arthura Levin , ,Quadrant Capital Group ,Privium Fund Management ,Nisa Investment Advisors ,Nasdaq ,Avidity Biosciences Company Profile ,Janney Montgomery Scott ,Avidity Biosciences Inc ,Cantor Fitzgerald ,Needham Company ,China Universal Asset Management Co ,Avidity Biosciences ,Get Free Report ,Director Arthur ,Investment Advisors ,Capital Group ,Universal Asset Management ,Avidity Biosciences Daily ,